Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Bruce Keyt"'
Autor:
Yue Wang, Jie Xue, Umesh Muchhal, Keyu Li, Angus Sinclair, Poonam Yakkundi, Rodnie Rosete, Bruce Keyt, Liqin Liu, Deepal Pandya, Vidhya Bai Krishnoji Rao, Elizabeth Perez, Paul Hinton, Gene Li, Kristene Mai, Nardeen Hanna, Zhongde Ye, Jinqiu Wang, Tina Mao, Palak Chudasama, Sachi Rahman, Zee Malik, Krzysztof Bzymek
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/48b4c1c1bc81453ba906e5b5b2b62cf8
Autor:
Umesh Muchhal, Angus Sinclair, Dean Ng, Bruce Keyt, Sarang Tartey, Vignesh Narayanaswamy, Deepal Pandya, Vidhya Bai Krishnoji Rao, Elizabeth Perez, Paul Hinton, Hyewon Phee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e16717cae9f944beb89fd9aa4f3af8ac
Autor:
Maya Kotturi, Mélanie Desbois, Angus Sinclair, Thierry Giffon, Dean Ng, Poonam Yakkundi, Marigold Manlusoc, Rodnie Rosete, Avneesh Saini, Bruce Keyt, Daniel Machado, Miho Oyasu, Susan Calhoun, Tasnim Kothambawala, Beatrice Wang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/7407df17c8fd4aeeb4c9fb58b7d3aba4
Autor:
Angus Sinclair, Thierry Giffon, Dean Ng, Poonam Yakkundi, Hope Lancero, Marigold Manlusoc, Rodnie Rosete, Avneesh Saini, Madeline Tran, Kevin Carlin, Chitra Saraiya, Ramesh Baliga, Bruce Keyt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f409f288839b4ef28aeb52ed133e3d6e
Autor:
Mélanie Desbois, Thierry Giffon, Poonam Yakkundi, Sivani Pandey, Rodnie Rosete, Daniel Machado, Marigold Manlusoc, Susan Calhoun, Tasnim Kothambawala, Jey Ananta, Kristina Koyama, Yuan Cao, Dean Ng, Tomas Miranda-Katz, Avneesh Saini, Abhinav Jain, Hongjun Yue, Yang Cai, Miho Oyasu, Liz Bogaert, Roel Funke, Genevive Hernandez, Denise Nagata, Maya Leabman, Eric Humke, Stephen Carroll, Beatrice Wang, Bruce Keyt, Angus Sinclair, Maya Kotturi
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Loretta Nastoupil, Elizabeth Budde, Won Seog Kim, Ajay Gopal, Chan Cheah, Ian Flinn, Gareth Gregory, Matthew Matasar, Catherine Diefenbach, Matthew Ku, Sung-Soo Yoon, Ibrahim Qazi, Rachel Wei, Maya Leabman, Genevive Hernandez, Iris Sison, Bruce Keyt, Thomas Manley, Phillipe Armand
Publikováno v:
Cancer Research. 82:CT125-CT125
Background: Recent advances in the treatment of non-Hodgkin lymphoma (NHL) have transformed the landscape and provided significant benefits to patients. Novel agents that target CD19 and CD20 on B cells, such as bispecific T-cell engagers and chimeri
Autor:
Thierry Giffon, Melanie Desbois, Poonam Yakkundi, Keerthana Sekar, Marigold Manlusoc, Rodnie Rosete, Daniel Machado, Susan Calhoun, Tasnim Kothambawala, Dean Ng, Vu Tran, Avneesh Saini, Abhinav Jain, Beatrice Wang, Maya Kotturi, Bruce Keyt, Angus Sinclair
Publikováno v:
Cancer Research. 82:3438-3438
Anti-PD-1/PD-L1 therapies are efficacious in certain cancer indications, but often patients relapse following a primary response Therefore rational combinations are needed to enhance initial and durable responses of anti-PD-1/PD-L1 therapies. Immunos
Autor:
Tasnim Kothambawala, Genevive Hernandez, Angus M. Sinclair, Bruce Keyt, Ling Wang, Marvin Peterson, Thomas J. Matthew, Beatrice Tien-Yi Wang, Avneesh Saini, Susan E. Calhoun, Eric W. Humke, Maya Kotturi
Publikováno v:
Molecular cancer therapeutics. 20(12)
Death receptor 5 (DR5) is an attractive target for cancer therapy due to its broad upregulated expression in multiple cancers and ability to directly induce apoptosis. Though anti-DR5 IgG antibodies have been evaluated in clinical trials, limited eff
Autor:
Rodnie Rosete, Poonam Yakkundi, Bruce Keyt, Thierry Giffon, Kevin Carlin, Ramesh Baliga, Dean Ng, Avneesh Saini, Hope Lancero, Marigold Manlusoc, Angus M. Sinclair, Madeline Tran, Chitra Saraiya
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Therapeutic antibodies inhibiting PD-1/PD-L1 have demonstrated clinical efficacy though only a fraction of patients respond. Combinations are being explored to enhance responses including anti-PD-1/PD-L1 IgG antibodies with IL-15-pathway s
Publikováno v:
Antibodies, Vol 9, Iss 53, p 53 (2020)
Antibodies
Antibodies
Natural immunoglobulin M (IgM) antibodies are pentameric or hexameric macro-immunoglobulins and have been highly conserved during evolution. IgMs are initially expressed during B cell ontogeny and are the first antibodies secreted following exposure